메뉴 건너뛰기




Volumn 24, Issue 3 B, 2004, Pages 1843-1851

Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer

Author keywords

Chemotherapy; Docetaxel; Gastric carcinoma; Phase I study; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR; DOCETAXEL; FLUOROURACIL;

EID: 3242679932     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (57)

References (44)
  • 2
    • 0028032976 scopus 로고
    • Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer; a prospective randomized trial of the Italian oncology group for clinical research
    • Cocconi G, Bella M, Zironi S, Algeri R, Costanzo FD, Lisi VD, Luppi G, Mazzocchi B, Rodino C, Soldani M, Gilli G and Finard C: Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer; A prospective randomized trial of the Italian oncology group for clinical research. J Clin Oncol 12: 2687-2693, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 2687-2693
    • Cocconi, G.1    Bella, M.2    Zironi, S.3    Algeri, R.4    Costanzo, F.D.5    Lisi, V.D.6    Luppi, G.7    Mazzocchi, B.8    Rodino, C.9    Soldani, M.10    Gilli, G.11    Finard, C.12
  • 5
    • 0028016155 scopus 로고
    • A phase II study in advanced gastroesophageal cancer using epirubicin and cisplatin in combination with infusion 5-fluorouracil (ECF)
    • Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N and Ford H: A phase II study in advanced gastroesophageal cancer using epirubicin and cisplatin in combination with infusion 5-fluorouracil (ECF). Ann Oncol 5: 609-616, 1994.
    • (1994) Ann Oncol , vol.5 , pp. 609-616
    • Findlay, M.1    Cunningham, D.2    Norman, A.3    Mansi, J.4    Nicolson, M.5    Hickish, T.6    Nicolson, V.7    Nash, A.8    Sacks, N.9    Ford, H.10
  • 6
    • 0023726563 scopus 로고
    • Report on nationalwide pooled data and cohort investigation in UFT Phase II study
    • Oka K, Taguchi T and Kimura K: Report on nationalwide pooled data and cohort investigation in UFT Phase II study. Cancer Chemother Pharmacol 22: 333-338, 1988.
    • (1988) Cancer Chemother Pharmacol , vol.22 , pp. 333-338
    • Oka, K.1    Taguchi, T.2    Kimura, K.3
  • 7
    • 9344248389 scopus 로고    scopus 로고
    • Antitumor activity of 1M tegafur - 0.4 M 5-chloro-2,4- dihydroxypyrimidine- 1 M potasium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats
    • Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fujioka A, Saito H, Oyama K, Takeda S, Unemi N and Fukushima M: Antitumor activity of 1M tegafur - 0.4 M 5-chloro-2,4-dihydroxypyrimidine- 1 M potasium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 56: 2602-2606, 1996.
    • (1996) Cancer Res , vol.56 , pp. 2602-2606
    • Shirasaka, T.1    Nakano, K.2    Takechi, T.3    Satake, H.4    Uchida, J.5    Fujioka, A.6    Saito, H.7    Oyama, K.8    Takeda, S.9    Unemi, N.10    Fukushima, M.11
  • 9
    • 0032819756 scopus 로고    scopus 로고
    • The S-1 Gastrointestinal Cancer Study Group: An early phase II study of oral S-1, a newly developed 5-fluoruracil derivative for advanced and recurrent gastrointestinal cancers
    • Sugimachi K, Maehara Y, Horikoshi N, Shimada Y, Sakata Y and Taguchi T, The S-1 Gastrointestinal Cancer Study Group: An early phase II study of oral S-1, a newly developed 5-fluoruracil derivative for advanced and recurrent gastrointestinal cancers. Oncology 57: 202-210, 1999.
    • (1999) Oncology , vol.57 , pp. 202-210
    • Sugimachi, K.1    Maehara, Y.2    Horikoshi, N.3    Shimada, Y.4    Sakata, Y.5    Taguchi, T.6
  • 10
    • 0032189218 scopus 로고    scopus 로고
    • Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M Gimestat - 1 M otastat potasium) in advanced gastric cancer patients
    • Sakata Y, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y and Taguchi T: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M Gimestat - 1 M otastat potasium) in advanced gastric cancer patients. Eur J Cancer 34: 1715-1720, 1998.
    • (1998) Eur J Cancer , vol.34 , pp. 1715-1720
    • Sakata, Y.1    Ohtsu, A.2    Horikoshi, N.3    Sugimachi, K.4    Mitachi, Y.5    Taguchi, T.6
  • 12
    • 0034029776 scopus 로고    scopus 로고
    • The S-1 gastrointestinal cancer study group: Phase II study of S-1, a novel derivative 5-fluorouracil, in advanced gastric cancer
    • Koizumi W, Kurihara M, Nakano S and Hasegawa K: The S-1 gastrointestinal cancer study group: Phase II study of S-1, a novel derivative 5-fluorouracil, in advanced gastric cancer. Oncology 58: 191-197, 2000.
    • (2000) Oncology , vol.58 , pp. 191-197
    • Koizumi, W.1    Kurihara, M.2    Nakano, S.3    Hasegawa, K.4
  • 13
    • 0037570623 scopus 로고    scopus 로고
    • S-1 in gastric cancer: A comprehensive review
    • Maehara Y: S-1 in gastric cancer: a comprehensive review. Gastric Cancer 6 (Suppl 1): 2-8, 2003.
    • (2003) Gastric Cancer , vol.6 , Issue.SUPPL. 1 , pp. 2-8
    • Maehara, Y.1
  • 14
    • 0026428123 scopus 로고
    • Studies with RP56976 (Taxotere): A semisynthetic analogue of taxol
    • Ringel I and Horwitz B: Studies with RP56976 (Taxotere): A semisynthetic analogue of taxol. J Natl Cancer Inst 83: 288-291, 1991.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 288-291
    • Ringel, I.1    Horwitz, B.2
  • 15
    • 0026667555 scopus 로고
    • Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
    • Kelland LR and Abel G: Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 30: 444-450, 1992.
    • (1992) Cancer Chemother Pharmacol , vol.30 , pp. 444-450
    • Kelland, L.R.1    Abel, G.2
  • 16
    • 0026688488 scopus 로고
    • Effects of taxotere on murine and human tumor cell lines
    • Riou JF, Naudin A and Lavelle F: Effects of taxotere on murine and human tumor cell lines. Biochem Biophys Res Commun 187: 164-170, 1992.
    • (1992) Biochem Biophys Res Commun , vol.187 , pp. 164-170
    • Riou, J.F.1    Naudin, A.2    Lavelle, F.3
  • 17
    • 0026425674 scopus 로고
    • Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a taxol analogue
    • Bissery MC, Guenard D, Vogelein G and Lavelle F: Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51: 4845-4852, 1991.
    • (1991) Cancer Res , vol.51 , pp. 4845-4852
    • Bissery, M.C.1    Guenard, D.2    Vogelein, G.3    Lavelle, F.4
  • 18
    • 0027516128 scopus 로고
    • Phase I and pharmacokinetic study of Taxotere(RP56976, NSC 628503) given as a short intravenous infusion
    • Extra JM, Rousseau F, Bruno R et al: Phase I and pharmacokinetic study of Taxotere(RP56976, NSC 628503) given as a short intravenous infusion. Cancer Res 53: 1037-1042, 1993.
    • (1993) Cancer Res , vol.53 , pp. 1037-1042
    • Extra, J.M.1    Rousseau, F.2    Bruno, R.3
  • 19
    • 0002129338 scopus 로고
    • Phase I and pharmacokinetic study of RP56976 in a new ethanol free formulation of Taxotere
    • abstr 208
    • Aapro MS, Zullian G, Alberto P et al: Phase I and pharmacokinetic study of RP56976 in a new ethanol free formulation of Taxotere. Ann Oncol 3: 53, (suppl 5, abstr 208), 1992.
    • (1992) Ann Oncol , vol.3 , Issue.SUPPL. 5 , pp. 53
    • Aapro, M.S.1    Zullian, G.2    Alberto, P.3
  • 20
    • 0027211031 scopus 로고
    • Phase I clinical trial of Taxotere administered as either 2-hour or 6-hour intravenous infusion
    • Burris H, Irvin R, Kuhn J et al: Phase I clinical trial of Taxotere administered as either 2-hour or 6-hour intravenous infusion. J Clin Oncol 11: 950-958, 1993.
    • (1993) J Clin Oncol , vol.11 , pp. 950-958
    • Burris, H.1    Irvin, R.2    Kuhn, J.3
  • 21
    • 0026471026 scopus 로고
    • Phase I trial of Taxotere: Five-day schedule
    • Pazdur R, Newman RA, Newman B et al: Phase I trial of Taxotere: Five-day schedule. J Natl Cancer Inst 84: 1781-1788, 1992.
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1781-1788
    • Pazdur, R.1    Newman, R.A.2    Newman, B.3
  • 22
    • 0027512095 scopus 로고
    • Phase I and pharmacokinetic study of Taxotere (RP56976) administered as a 24-hour infusion
    • Bissett D, Setanoians A, Cassidy J et al: Phase I and pharmacokinetic study of Taxotere (RP56976) administered as a 24-hour infusion. Cancer Res 53: 523-527, 1993.
    • (1993) Cancer Res , vol.53 , pp. 523-527
    • Bissett, D.1    Setanoians, A.2    Cassidy, J.3
  • 23
    • 0028291647 scopus 로고
    • Phase I study of docetaxel administered as 1-hour intravenous infusion on a week basis
    • Tomiak E, Piccart MJ, Kerger J et al: Phase I study of docetaxel administered as 1-hour intravenous infusion on a week basis. J Clin Oncol 12: 1458-1467, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 1458-1467
    • Tomiak, E.1    Piccart, M.J.2    Kerger, J.3
  • 24
    • 0028130156 scopus 로고
    • An early phase II clinical study of RP 56976 (Docetaxel) in patients with cancer of the gastrointestinal tract
    • in Japanese
    • Taguchi T: An early phase II clinical study of RP 56976 (Docetaxel) in patients with cancer of the gastrointestinal tract. Jpn J Cancer Chemother 26: 2431-2437, 1994. (in Japanese)
    • (1994) Jpn J Cancer Chemother , vol.26 , pp. 2431-2437
    • Taguchi, T.1
  • 25
    • 18144450345 scopus 로고    scopus 로고
    • Late phase II clinical study of RP56976 (Docetaxel) in patients with advanced/recurrent gastric cancer: A Japanese cooperative study group trial (Group A)
    • Taguchi T, Sakata Y, Kanamaru R, Kurihara M, Suminaga M, Ota J and Hirabayashi N: Late phase II clinical study of RP56976 (Docetaxel) in patients with advanced/recurrent gastric cancer: A Japanese cooperative study group trial (Group A). Jpn J Cancer Chemother 25: 1915-1924, 1998.
    • (1998) Jpn J Cancer Chemother , vol.25 , pp. 1915-1924
    • Taguchi, T.1    Sakata, Y.2    Kanamaru, R.3    Kurihara, M.4    Suminaga, M.5    Ota, J.6    Hirabayashi, N.7
  • 26
    • 2342465869 scopus 로고    scopus 로고
    • A late phase II clinical study of RP56976 (Docetaxel) in patients with advanced or recurrent gastric cancer: A cooperative study group trial (Group B)
    • Mai M, Sakata Y, Kanamaru R, Kurihara M, Suminaga M, Ota J, Hirabayashi N, Taguchi T and Furue H: A late phase II clinical study of RP56976 (Docetaxel) in patients with advanced or recurrent gastric cancer: A cooperative study group trial (Group B). Jpn J Cancer Chemother 26: 487-496, 1999.
    • (1999) Jpn J Cancer Chemother , vol.26 , pp. 487-496
    • Mai, M.1    Sakata, Y.2    Kanamaru, R.3    Kurihara, M.4    Suminaga, M.5    Ota, J.6    Hirabayashi, N.7    Taguchi, T.8    Furue, H.9
  • 28
    • 0034830598 scopus 로고    scopus 로고
    • Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reaction
    • Yamada Y, Shirao K, Ohtsu A, Boku N, Hyodo I, Saitoh H, Miyata Y and Taguchi T: Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reaction. Ann Oncol 12: 1133-1137, 2001.
    • (2001) Ann Oncol , vol.12 , pp. 1133-1137
    • Yamada, Y.1    Shirao, K.2    Ohtsu, A.3    Boku, N.4    Hyodo, I.5    Saitoh, H.6    Miyata, Y.7    Taguchi, T.8
  • 29
    • 0034856122 scopus 로고    scopus 로고
    • Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: Effects on mouse mammary tumor cell line MM2 in vitro and in vivo
    • Takeda Y, Yoshizaki I, Nonaka Y, Yanagie H, Matsuzawa A and Eriguchi M: Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo. Anti-Cancer Drugs 12: 691-698, 2001.
    • (2001) Anti-Cancer Drugs , vol.12 , pp. 691-698
    • Takeda, Y.1    Yoshizaki, I.2    Nonaka, Y.3    Yanagie, H.4    Matsuzawa, A.5    Eriguchi, M.6
  • 31
    • 0026439301 scopus 로고
    • Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method
    • Verginol JC, Bruno R, Montay G and Frydman A: Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method. J Chromatogr 582: 273-278, 1992.
    • (1992) J Chromatogr , vol.582 , pp. 273-278
    • Verginol, J.C.1    Bruno, R.2    Montay, G.3    Frydman, A.4
  • 33
    • 0022448330 scopus 로고
    • Distribution and inhibition of dihydropyrimidine dehydrogenase activities in human tissues using 5-fluorouracil as a substrate
    • Ho DH, Townsend L, Luna MA and Body GP: Distribution and inhibition of dihydropyrimidine dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res 6: 781-784, 1986.
    • (1986) Anticancer Res , vol.6 , pp. 781-784
    • Ho, D.H.1    Townsend, L.2    Luna, M.A.3    Body, G.P.4
  • 34
    • 0030853620 scopus 로고    scopus 로고
    • Enhancing 5-fluorouracil cytotoxcity by inhibiing dihydropyrimidine dehydrogenase activity with uracil in human tumor cells
    • Takechi T, Uchida J, Fujioka A and Fukushima M: Enhancing 5-fluorouracil cytotoxcity by inhibiing dihydropyrimidine dehydrogenase activity with uracil in human tumor cells. Int J Oncol 11: 1041-1044, 1997.
    • (1997) Int J Oncol , vol.11 , pp. 1041-1044
    • Takechi, T.1    Uchida, J.2    Fujioka, A.3    Fukushima, M.4
  • 36
    • 0037908625 scopus 로고    scopus 로고
    • Future prospects of personalized chemotherapy in gastric cancer patients: Results of a prospective randomized pilot study
    • Yoshida K, Tanabe K, Ueno H, Ohta K, Hihara J, Toge T and Nishiyama M: Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study. Gastric Cancer 6 (Suppl 1): 82-89, 2003.
    • (2003) Gastric Cancer , vol.6 , Issue.SUPPL. 1 , pp. 82-89
    • Yoshida, K.1    Tanabe, K.2    Ueno, H.3    Ohta, K.4    Hihara, J.5    Toge, T.6    Nishiyama, M.7
  • 37
    • 0030975059 scopus 로고    scopus 로고
    • Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
    • Chung Y, Yamashita Y, Matsuoka T, Nakata T, Onoda T, Maeda K, Sawada K, Kato Y, Shirasaka T and Sowa M: Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 80: 1-7, 1997.
    • (1997) Cancer , vol.80 , pp. 1-7
    • Chung, Y.1    Yamashita, Y.2    Matsuoka, T.3    Nakata, T.4    Onoda, T.5    Maeda, K.6    Sawada, K.7    Kato, Y.8    Shirasaka, T.9    Sowa, M.10
  • 38
    • 0034524342 scopus 로고    scopus 로고
    • An analysis of the therapeutic efficacy of protracted infusion of low-dose 5-fluorouracil and cisplatin in advanced gastric cancer
    • Kim R, Nishimoto N, Inoue H, Yoshida K and Toge T: An analysis of the therapeutic efficacy of protracted infusion of low-dose 5-fluorouracil and cisplatin in advanced gastric cancer. J Infect Chemother 6: 222-228, 2000.
    • (2000) J Infect Chemother , vol.6 , pp. 222-228
    • Kim, R.1    Nishimoto, N.2    Inoue, H.3    Yoshida, K.4    Toge, T.5
  • 39
    • 0019424961 scopus 로고
    • The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L 1210 cells
    • Cadman E, Heiner R and Benz C: The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. J Biol Chem 25: 1695-704,1981.
    • (1981) J Biol Chem , vol.25 , pp. 1695-1704
    • Cadman, E.1    Heiner, R.2    Benz, C.3
  • 40
    • 0038246284 scopus 로고    scopus 로고
    • Experimental study to evaluate the usefulness of S-1 in a model of peritoneal dissemination of gastric cancer
    • Mori T, Fujiwara Y, Yano M, Tamura S, Yasuda T, Takiguchi S and Monden M: Experimental study to evaluate the usefulness of S-1 in a model of peritoneal dissemination of gastric cancer. Gastric Cancer 6 (Suppl 1): 13-18, 2003.
    • (2003) Gastric Cancer , vol.6 , Issue.SUPPL. 1 , pp. 13-18
    • Mori, T.1    Fujiwara, Y.2    Yano, M.3    Tamura, S.4    Yasuda, T.5    Takiguchi, S.6    Monden, M.7
  • 43
    • 0033933427 scopus 로고    scopus 로고
    • A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
    • Colevas AD, Adak S, Amerin PC, Barton JJ, Costello R and Poner MR: A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck. Ann Oncol 11: 535539, 2000.
    • (2000) Ann Oncol , vol.11 , pp. 535539
    • Colevas, A.D.1    Adak, S.2    Amerin, P.C.3    Barton, J.J.4    Costello, R.5    Poner, M.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.